Can I use the first reference genome I selected for the transcriptomics test at NCBI, which has the same Latin name but only a 60% alignment rate? Or is it recommended to choose a non-reference genome?
In transcriptomics analysis, selecting an appropriate reference genome is crucial for the reliability and biological significance of the results. If the alignment rate is only 60%, this may indicate the following issues:
Potential Causes of Low Alignment Rate:
1. Incomplete or mismatched reference genome
(1) The reference genome you selected may be outdated and may not contain all gene sequences of the sample species.
(2) Check for the latest reference genome version for the species or updated annotation files.
2. Species differences
(1) Even if the sample and reference genome belong to the same genus or species, significant differences in sub-species, geographical populations, or genetic background may lead to low alignment rates.
(2) The transcriptome sample may contain variant genes specific to certain populations that are not well represented in the reference genome.
3. Sample quality or handling issues
(1) The transcriptome sample may contain contaminant sequences (e.g., bacterial or other species RNA), leading to a reduced effective alignment rate.
(2) Sample processing steps (such as adapter contamination and low-quality reads) may reduce alignment effectiveness.
4. Technical factors
(1) The parameter settings of the alignment tool (e.g., mismatch allowance) may not be lenient enough.
(2) The length or quality distribution of RNA sequencing reads may not meet the optimal conditions for the alignment tool.
Impact of Low Alignment Rate:
Low alignment rates may lead to:
1. Inaccurate expression quantification: A large number of reads failing to align will lead to underestimation of specific gene expression levels.
2. Insufficient functional annotation: Important functional genes may be lost if they do not align with regions in the reference genome.
3. Bias in downstream analysis: Results of differential expression analysis or GO/KEGG enrichment analysis may be distorted.
Applicability of Reference-Free Analysis:
1. Reference-free analysis (de novo assembly) is suitable for the following situations:
(1) No suitable reference genome: For example, the target species is an unsequenced non-model organism.
(2) Low alignment rate with distantly related species: Insufficient match with the reference genome (e.g., <70%).
(3) Research targets include new genes or specific variants: Such as novel transcripts or gene variants in the sample not annotated in the reference genome.
2. The advantage of reference-free analysis is independence from a reference genome, allowing discovery of new sequences in the sample, but it presents the following challenges:
(1) High computational resource requirements: Requires substantial computational resources for assembly and annotation.
(2) Lower reliability: Assembly quality (e.g., contig integrity and accuracy) may be inferior to reference-based analysis.
(3) Annotation depends on public databases: Reliance on functional annotation may result in incomplete information.
Optimization Strategies:
1. Try a better reference genome
(1) Check if there is a newer version of the reference genome for the species.
(2) If there are significant sub-species differences, try using a reference genome closer to your sample's sub-species.
(3) Consider a mixed reference genome: If your species is close to multiple reference species, construct a combined reference genome.
2. Optimize the alignment process
(1) Optimization of alignment tool parameters
-
Adjust mismatch allowance and gap penalty for alignment tools (e.g., HISAT2, STAR).
-
Use tools better suited for high diversity (e.g., Subread).
(2) Quality control
-
Ensure good quality distribution of raw reads, remove adapters and low-quality sequences.
-
Check for contamination by non-target species.
3. Implement a mixed strategy
(1) Conduct both reference-based alignment and de novo assembly, and integrate results.
(2) Tools like StringTie or Trinity can be used to combine de novo assembly results with the reference genome to improve annotation rates.
4. Considerations for reference-free analysis
(1) When no suitable reference genome can be found, try reference-free analysis and use public databases for functional annotation (e.g., NR, SwissProt, Pfam).
(2) Subsequently, use BUSCO to assess the completeness of the de novo assembly to ensure reliability.
Decision Suggestions:
1. If the alignment rate consistently stays below 70% and cannot be improved: Consider choosing reference-free analysis or a mixed strategy.
2. If you can optimize the reference genome or alignment parameters: Prioritize improving the reference-based alignment process, as reference-based analysis offers advantages for functional annotation and downstream analysis.
Biotech Pioneer - A leading service provider for biomolecule characterization and multi-omics mass spectrometry detection.
Related Services:
How to order?






